The landscape of dementia prognosis has evolved substantially with the arrival of sophisticated biomarkers, including amyloid PET scans, tau imaging, and blood-dependent assessments that will detect Alzheimer's pathology a long time just before indicators emerge. Even though these technological developments represent extraordinary progress in knowing neurodegenerative diseases, they m... https://fridaf197blt5.liberty-blog.com/profile